Financials
- Market Capitalization 220.29 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.53
市销率
8.08
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3451 | KROS Keros Therapeutics, Inc. - common stock | 11.61 USD | -2.85% | +0.43% | +4.59% | -23.11% | 230.19 M USD | ||
| 3469 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.78 USD | +0.72% | +3.73% | +6.11% | -4.79% | 223.99 M USD | ||
| 3479 | STRO Sutro Biopharma, Inc. - Common Stock | 13.28 USD | -6.94% | -12.29% | -22.29% | -23.63% | 220.20 M USD | ||
| 3494 | TRDA Entrada Therapeutics, Inc. - Common Stock | 5.50 USD | -3.00% | -0.36% | -19.12% | -21.09% | 214.15 M USD |